Life Sciences

Is Safety Endangered in Gene Therapy Trials?
Public Policy Is Safety Endangered in Gene Therapy Trials?

The gene therapy industry is at a crucial juncture, with recent events prompting intense scrutiny over patient safety in clinical trials. The halt of Sarepta Therapeutics' trials by the U.S. Food and Drug Administration (FDA) serves as a stark reminder of the inherent risks associated with

Biopharma Faces Regulatory Shift: FDA, Trials, and Mergers
Public Policy Biopharma Faces Regulatory Shift: FDA, Trials, and Mergers

The biopharmaceutical sector is currently experiencing a dynamic phase marked by regulatory reforms, technological growth, and strategic corporate actions. This environment presents both challenges and opportunities for industry players, prompting adaptive strategies to thrive in an evolving

Can Blood Biomarkers Revolutionize Alzheimer's Diagnosis?
Care Can Blood Biomarkers Revolutionize Alzheimer's Diagnosis?

As the global population ages, a silent crisis is looming on the horizon: Alzheimer's disease, a condition affecting millions worldwide. What if a simple blood test could revolutionize the diagnosis of Alzheimer's, making early detection more accessible and affordable? The potential of

UK Biobank Pioneers Global Advances in Medical Imaging
Technology UK Biobank Pioneers Global Advances in Medical Imaging

In the realm of medical technology and diagnostics, Faisal Zain stands out as a beacon of innovation and expertise. Specializing in the manufacturing and development of medical devices, Faisal has been instrumental in advancing medical research tools. In this interview, we explore the intricacies

AI Revolutionizes Oncology: Rakovina's Cutting-Edge Strategies
Care AI Revolutionizes Oncology: Rakovina's Cutting-Edge Strategies

In recent years, the integration of artificial intelligence in oncology has been nothing short of revolutionary, fundamentally altering the landscape of cancer treatment and diagnosis. AI has carved a path for enhanced precision in medicine, offering new methodologies that were previously

Can Cosentyx Transform GCA Treatment Amidst Challenges?
Care Can Cosentyx Transform GCA Treatment Amidst Challenges?

As the global population ages, diseases like Giant Cell Arteritis (GCA), which predominantly impact individuals over 50, are coming under increased scrutiny due to their debilitating effects. GCA, an autoimmune disorder that causes inflammation of blood vessels in the head and neck, can lead to

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later